INTRODUCTION
============

Nearly half a century has passed since the introduction of Fontan operation.^[@ref1]^ It was initially developed as the surgery for tricuspid atresia but today generally for complex congenital heart diseases to which biventricular repair is impossible. The procedure has contributed greatly to the improvement of mortality rate in these patients. However, as it is a palliative procedure, the majority of patients with Fontan circulation have been reported to suffer from impaired functional capacity and various complications including augmented exercise ventilation.^[@ref2]-[@ref4]^

However, it is still unsettled if it is due to increased pulmonary dead space or augmented central or peripheral ventrilatory drive during exercise.^[@ref4]-[@ref7]^ The majority of previous studies report that the lack of pulmonary pump in Fontan circulation causes maldistribution of pulmonary blood flow and ventilation/perfusion (V̇/Q̇) mismatch, leading to increased dead space ventilation.^[@ref5],[@ref8]^ On the other hand, Ohuchi and coauthors have reported that a steeper minute ventilation-carbon dioxide production slope (the V̇E/V̇CO~2~ regression slope) was related with lower resting carbon dioxide tension (PaCO~2~) as well as with lower resting arterial saturation, suggesting augmented peripheral and/or central ventilatory drive during exercise in Fontan patients.^[@ref4],[@ref9]^

The primary objective of the present study was, therefore, to test whether the augmented exercise ventilation in Fontan patients is due to increased pulmonary dead space or accentuated central and/or peripheral ventrilatory drive during exercise. Also, if the latter is the case, we would try to seek for the underlying conditions related with exercise hyperventilation in Fontan patients.

METHODS
=======

Study subjects
--------------

The present study is a single-center retrospective study. The inclusion criteria were: 1) subjects who had undergone cardiopulmonary exercise testing (CPX) for the evaluation of exercise tolerance during the period between January 2015 and August 2018, and 2) those who had been operated on for single ventricle with the Fontan operation (the total cavo-pulmonary connection method: TCPC) in Aichi Children's Health and Medical Center. A total of 26 consecutive patients served as the study subjects (the Fontan group). It accounted for 74% of the total subjects who had undergone TCPC in our institute. The average period between Fontan operation and the CPX was 83 (s.d. = 45) months. Two groups of subjects served as controls: the biventricularly repaired (Bi) group, and the "true" control (C) group. The Bi group consisted of 18 patients with various congenital heart defects who had undergone biventricular cardiac repair. The C group consisted of 29 subjects with various mild medical conditions (i.e. mild arrhythmias that disappeared during exercise testing, or chest pain that later proved to be normal, or subjects with a history of Kawasaki disease without cardiac involvements) ([Table 1](#table1){ref-type="table"}). The characteristics of the subjects are listed in [Table 2](#table2){ref-type="table"}. A physician's interviews and physical examinations revealed that they were in good conditions and judged to be tolerable for the symptom-limited treadmill exercise testing. None of the subjects was a habitual smoker. Written informed consent was obtained from each participant and/or their parents after explanation of the objective of the exercise testing. This study has been approved by the ethics committee of Chubu University and Aichi Children's Health and Medical Center.

###### 

Diagnosis of the study subjects of the 3 groups

  ----------------------------------------------------------------------------------------------------------------------
  Fontan\    Biventricularly repaired\   Control\                                                                  
  (n = 26)   (n = 18)                    (n = 29)                                                                  
  ---------- --------------------------- ---------- ------- ----- -- --------------------------------------------- -----
             *n*                                            *n*                                                    *n*

  DORV+PS    8                                      AS      4        arrhythmias                                   10

  PAIVS      5                                      VSD     3        Suspected LQTS                                6

  TA         3                                      CoA     2        Chest pain without underlying heart disease   4

  d-TGA      3                                      DORV    2        History of KD without CAL                     4

  AVSD+PS    2                                      c-TGA   2        Pre-syncope                                   3

  HLHS       2                                      TOF     2        WPW syndrome without PSVT                     2

  other      3                                      other   3                                                      
  ----------------------------------------------------------------------------------------------------------------------

Abbreviations: AS: aortic stenosis, AVSD: atrioventricular septal defect, CAL: coronary arterial lesion, CoA: coarctation of the aorta, c-TGA: congeniltally corrected transposition of the great arteries, DORV: double outlet right ventricle, d-TGA: d-transposition of the great arteries, HLHS: hypoplastic left heart syndrome, KD: Kawasaki disease, LQTS: long-QT syndrome, PAIVS: pulmonary atresia with intact ventricular septum, PS: pulmonary stenosis, PSVT: paroxsysmal supraventricular tachycardia, TA: tricuspid atresia, TOF: tetralogy of Fallot, VSD: ventricular septal defect, WPW: Wolf-Parkinson-White syndrome

###### 

Characteristics of the subjects and the results of cardiopulmonary exercise testing in the three study groups

  ---------------------------------------------------------------------------------------------------------
                                   Fontan\            Biventricularly repaired\   Control\      *p* value
                                   (n = 26)           (n = 18)                    (n = 29)      
  -------------------------------- ------------------ --------------------------- ------------- -----------
  female/male                      12/14              8/10                        14/15         

  age (y.o.)                       8.5 (3.0)          9.8 (3.5)                   9.3 (1.6)     0.28

  height (cm)                      125 (17) ^a,b^     137 (23)                    137 (11)      0.02

  weight (kg)                      26 (10) ^a,b^      37 (20)                     33 (10)       0.02

  HR~peak~ (bets/min)              175 (18)           171 (21)                    183 (20)      0.07

  RER~peak~                        1.03 (0.06)        1.03 (0.06)                 1.03 (0.07)   0.99

  V̇O~2peak~ (ml/min)               1066 (489) ^a,b^   1525 (692)                  1468 (354)    0.004

  V̇O~2peak~(ml/min/kg)             41.0 (8.4)         43.5 (6.6)                  45.9 (11.6)   0.16

  V̇O~2VAT~ (ml/min)                656 (232) ^a,b^    946 (373)                   939 (248)     \<0.001

  V̇O~2VAT~ (ml/min/kg)             26.0 (5.3)         28.0 (6.6)                  29.2 (8.3)    0.24

  OUES (ml/min)                    1313 (443) ^b^     1579 (660)                  1618 (333)    0.046

  OUES (ml/min/kg)                 52.6 (11.6)        45.9 (8.9)                  50.3 (10.5)   0.12

  V̇E/V̇CO~2~ regression slope       35.5 (5.3) ^a,b^   28.7 (3.8)                  29.5 (3.0)    \<0.001

  V̇A/V̇CO~2~ regression slope       26.9 (3.4) ^a,b^   21.0 (2.0)                  21.6 (2.1)    \<0.001

  FetCO~2VAT~ (%)                  4.4 (0.5) ^a,b^    5.5 (0.5)                   5.5 (0.4)     \<0.001

  PaCO~2VAT~ (torr)                33.7 (3.2) ^a,b^   40.7 (3.1)                  40.7 (2.8)    \<0.001

  V~d~/V~tVAT~                     0.33 (0.06)        0.33 (0.04)                 0.35 (0.05)   0.54

  OP~VAT~ (ml/beat)                5.2 (1.8) ^a,b^    7.5 (3.6)                   6.5 (1.7)     0.006

  OP~VAT~/body mass (ml/beat/kg)   0.21 (0.04)        0.21 (0.03)                 0.20 (0.05)   0.69
  ---------------------------------------------------------------------------------------------------------

The mean values are tested by the analysis of variance (ANOVA). The post hoc tests are calculated with the Bonferroni's method. a: p\<0.05 between the Fontan group and the biventyricularly repaired group; b: p\<0.05 between the Fontan group and the control group.

Abbreviations: FetCO~2VAT~: mixed end-expiratory carbon dioxide concentration, HR~peak~: heart rate at peak exercise, OP~VAT~: oxygen pulse at the ventilatory anaerobic threshold, OUES: oxygen uptake efficiency slope, PaCO~2VAT~: arterial carbon-dioxide partial pressure at the ventilatory anaerobic threshold, RER~peak~: respiratory exchange ratio at peak exercise, V̇A: alveolar minute ventilation, VAT: ventilatory anaerobic threshold, V̇CO~2~: carbon-dioxide production, V~d~/V~tVAT~: the dead-space fraction at the ventilatory anaerobic threshold, V̇E: minute ventilation. V̇O~2peak~: oxygen uptake at peak exercise, V̇O~2VAT~: oxygen uptake at the ventilatory threshold.

Exercise tests
--------------

Exercise tests were performed on a treadmill (MAT-2500, Fukuda Denshi Co. Ltd., Tokyo, Japan) with a standard symptom-limited Bruce protocol. An ECG and the heart rate were monitored throughout the test with the stress test system (ML-5000, Fukuda Denshi Co. Ltd., Tokyo, Japan). The cuff blood pressure was also measured every minute with an automatic indirect manometer (STBP-680F, Collin Denshi, Nagoya, Japan).

Analysis of expired gas
-----------------------

Carbon dioxide production \[V̇CO~2~ (mL/min, STPD)\], oxygen uptake \[V̇O~2~ (mL/min, STPD)\], minute ventilation \[V̇E (L/min, BTPS)\], tidal volume (mL), the respiratory rate (breaths/min), the mixed end-expiratory carbon dioxide concentration \[FetCO~2~: (%)\], and the mixed end-expiratory oxygen concentration \[FetO~2~: (%)\] were continuously measured on a breath-by-breath basis with the Minato AE-310S metabolic measurement cart (Minato Medical Science, Osaka, Japan). To reduce breath-by-breath "noise," data were processed with a five-breath moving average filter.

Alveolar minute ventilation \[V̇A (L/min, BTPS)\] was derived from the following equation: where V~d~/V~t~ is the ratio of the pulmonary dead space to tidal volume derived from the following alveolar gas equation.^[@ref10],[@ref11]^

V̇A = 863 · V̇CO~2~/PaCO~2~

V~d~/V~t~ = 1 --V̇A/V̇E

The PaCO~2~ was estimated noninvasively by the following equation derived from regression analysis of the relationships among PaCO~2~, PetCO~2~, and V~t~ during exercise.^[@ref10]^

PaCO~2~ = 5.5 + 0.9 · PetCO~2~ -- 0.0021 · V~t~

Ventilatory response to exercise was assessed by the slope of the relationship between V̇E and V̇CO~2~ (the V̇E/V̇CO~2~ regression slope). We also calculated the slope of the relationship between V̇A and V̇CO~2~ during incremental exercise (V̇A/V̇CO~2~ regression slope) for the evaluation of carbon dioxide mediated peripheral/central ventilatory drive during exercise.^[@ref11]^ The slopes were determined by linear regression analysis of the relationship between V̇E and V̇CO~2~ or between V̇A and V̇CO~2~ during exercise using data obtained before the occurrence of respiratory compensation.

The ventilatory anaerobic threshold (VAT) was defined as the level of V̇O~2~ at which an increase in the V̇E/V̇O~2~ without a simultaneous increase in V̇E/V̇CO~2~, or the disappearance of the linear relationship between V̇CO~2~ and V̇O~2~ (the V-slope method).^[@ref12]^ The oxygen uptake efficiency slope was calculated by the logarithmic relation between V̇O~2~ and the V̇E during incremental exercise.^[@ref13]^

The PaCO~2~ and V~d~/V~t~ during exercise were determined from data obtained during 30 s at the VAT and during the final 30 s of peak exercise. We used the average of the 30 s data for analysis.

Statistical analysis
--------------------

Data are expressed as average +/-- s.d. Relationships between two measurements were analyzed with regression analysis. Measurements obtained from the three groups were compared with the analysis of variance. Post hoc tests were further analyzed by Bonferroni test. A level of *p* \< 0.05 was accepted as statistically significant.

RESULTS
=======

Characteristics of the subjects, as well as the results of cardiopulmonary exercise testing in the three study groups are listed in [Table 2](#table2){ref-type="table"}. It shows that the Fontan subjects have statistically lower values of V̇O~2peak~, V̇O~2VAT~ and OUES. These differences, however, disappear after corrections by body mass. On the other hand, Fontan subjects show augmented exercise ventilation characterized by the steeper V̇E/V̇CO~2~ regression slope ([Table 1](#table1){ref-type="table"}). This is caused by exercise hyperventilation, or augmented central/peripheral ventilatory drive in Fontan subjects: they show steeper V̇A/V̇CO~2~ regression slope, as well as lower PaCO~2VAT~ and FetCO~2VAT~ than the two control groups. On the other hand, the dead-space ventilation fraction (V~d~/V~tVAT~), another possible determinant of exercise ventilation, was not different among the three groups. Also in the Fontan subjects, SaO~2rest~, which is considered to be caused by ventilation/perfusion (V̇/Q̇) mismatch^[@ref8],[@ref14]^ or the intrapulmonary, coronary sinus to pulmonary venous, or intra-cardiac right to left shunts,^[@ref3]^ was correlated with PaCO~2VAT~ and FetCO~2VAT~ ([Figure 1](#fig1){ref-type="fig"}).

![Contributions of residual hypoxemia to exercise hyperventilation in Fontan patients\
Relationships of alveolar ventilation/carbon-dioxide (V̇A/V̇CO~2~) regression slope (a), mixed end-expiratory carbon-dioxide concentration at the ventilatory threshold (FetCO~2VAT~, b), and arterial carbon-dioxide partial pressure at the ventilatory threshold (PaCO~2VAT~, c) between arterial oxygen saturation at rest (SaO~2~).](2186-3326-82-0281-g001){#fig1}

DISCUSSION
==========

The main results of the present study are:

1\) Patients with Fontan circulation have almost normal exercise tolerance, at least after corrections by body mass, but have impaired ventilatory response to exercise.

2\) Augmented central and/or peripheral ventilatory drive, not increased dead space ventilation, is proven to be the main cause of exercise hyperventilation.

3\) Residual hypoxemia after Fontan procedure further drives exercise ventilation.

Numerous past studies have reported reduced V̇O~2peak~ in Fontan subjects.^[@ref15]-[@ref20]^ For example, Müller and coauthors have reported that Fontan (TCPC) subjects showed the average V̇O~2peak~ of 25.0ml/min/kg, corresponding to only 59.7% of age-and sex-related reference value.^[@ref18]^ These results are in contrast to those of the present study showing the average V̇O~2peak~ of 41.0 ml/min/kg, almost normal value corresponding to 90% of the average value of the control subjects. Exercise intensity reached in the CPX sessions, indicated by the RER~peak~ and HR~peak~, was not different among the three study groups. The reason for the excellent exercise tolerance in our Fontan subjects is uncertain. This might be resulted from the excellence of our cardiac surgeons. Or it might be the results of selection bias: only those subjects with excellent post-surgical clinical course might have been selected for CPX. This, however, would be impossible, as the study participants accounted for most subjects (74%) who had undergone TCPC surgery in our institute.

In contrast to their almost normal exercise tolerance, our study subjects with Fontan circulation are shown to have augmented exercise ventilation, which is in accordance with previous studies.^4,21-23^ This phenomenon can be explained by two different mechanisms: increased dead space fraction caused by V̇/Q̇ mismatch^[@ref7],[@ref8],[@ref14]^ and/or exercise hyperventilation.^4,7,9,25^ Matsushita et al have shown, with the xenon-133 lung scanning, abnormal distribution of pulmonary blood flow to the upper lobes compared to normal subjects, causing V̇/Q̇ mismatch in Fontan subjects.^[@ref8]^ Another possible mechanism is exercise hyperventilation. Mertens et al are perhaps the first authors who have reported exercise hyperventilation in Fontan subjects.^[@ref7]^ They suggested hyperventilation in these subjects was caused by early occurrence of VAT. However, this speculation would only partially explain the phenomenon. Results of the present study that Fontan subjects had lower PaCO~2VAT~ and FetCO~2VAT~, as well as steeper V̇A/V̇CO~2~ regression slope showed hyperventilation was observed before the occurrence of VAT. Perhaps, explanations by Ohuchi et al would be more reasonable. They considered that enhanced central chemo-sensitivity,^[@ref9]^ often observed in patients with heart failure, as well as greater V~d~/V~t~ was the main reason for their exercise hyperventilation.^[@ref9]^ However, this also would explain the phenomenon only partially, as hyperventilation was observed in our Fontan subjects without heart failure who had normal V̇O~2peak~ and OUES in the present study. Perhaps, explanations in the Ohuchi's older study that reduction in vital capacity and high pulmonary wedge pressure in Fontan subjects lead to arterial desaturation and subsequent hyperventilation during exercise.^[@ref4]^

The present study also shows that some of our Fontan patients have mildly reduced SaO2rest, the degree of which is correlated with V̇A/V̇CO~2~ regression slope, PaCO~2VAT~, and FetCO~2VAT~. Several past studies also deal with the relation.^3,4,\ 24,25^ Meadows et al^[@ref3]^ and Rhodes et al^[@ref24]^ speculated that elevated V̇E/V̇CO~2~ regression slope and low FetCO~2~ during exercise is due to the right-to-left shunt of CO~2~-rich systemic venous blood. The consequent increase in PaCO~2~ is sensed by chemoreceptors, inducing central nervous system respiratory centers to increase the patient's respiratory drive and causing the V̇E/V̇CO~2~ regression slope to rise.^[@ref23],[@ref24]^ However, they failed to explain why "hyperventilation", i.e. reduction in PetCO~2~ occurs. Entering CO~2~-rich blood into the systemic circulation surely drives ventilation to eliminate the carbon dioxide from the arterial blood to "normalize" the carbon-dioxide level, but never to the level to cause hyperventilation.

Instead, we consider the exercise hyperventilation in Fontan patients can be explained by "the ventilatory acclimatization to hypoxia (VAH)". The VAH is an adaptation mechanism to chronic hypoxemia to increase ventilation that involves neural plasticity in both carotid body chemoreceptors and brainstem respiratory centers, often observed in subjects who have moved to the high altitude environments.^[@ref26],[@ref27]^ Basaran and coauthors have suggested that, as VAH is generally thought to be advantageous to increase arterial O~2~ levels over time in subjects with hypoxemia, this could also be beneficial for patients with chronic hypoxemia from lung diseases.^[@ref28]^ If it is the case, it would be no wonder that VAH is also observed in patients with chronic hypoxemia associated with cyanotic congenital heart diseases. Of course this explanation is only a hypothesis without any direct evidence to support it. However, results of the present study that SaO~2~ is correlated with V̇A/V̇CO~2~ regression slope, PaCO~2VAT~, and FetCO~2VAT~ would support this hypothesis.

In conclusion, the messages of the present study are, 1) patients with Fontan circulation have, in spite of almost normal exercise tolerance, increased ventilatory response to exercise, 2) augmented central and/or peripheral ventilatory drive, not increased dead space ventilation, is the main cause of exercise hyperventilation, which is further augmented by residual hypoxemia, perhaps by the mechanisms of VAH.
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CPX

:   cardiopulmonary exercise testing

FetO~2~

:   the mixed end-expiratory oxygen concentration

HR~peak~

:   peak heart rate

OUES

:   oxygen uptake efficiency slope

PetCO~2~

:   end-expiratory partial pressure of carbon dioxide

RER~peak~

:   respiratory exchange ratio

SaO~2rest~

:   arterial oxygen saturation at rest

TCPC

:   the total cavo-pulmonary connection

V̇A

:   Alveolar minute ventilation

VAH

:   ventilatory acclimatization to hypoxia

V̇CO~2~

:   Carbon dioxide production

V~d~/V~t~

:   the ratio of the pulmonary dead space to tidal volume

V̇O~2~

:   oxygen uptake

V̇O~2peak~

:   peak oxygen uptake

V̇O~2VAT~

:   ventilator threshold

V̇/Q̇ mismatch

:   ventilation/perfusion mismatch

V~t~

:   tidai volume
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